<unk>  is an antimetabolite that is FDA approved for the treatment of adjuvant colon cancer, metastatic colorectal cancer, metastatic breast cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include diarrhea, hand-and-foot syndrome, nausea, vomiting, abdominal pain, fatigue/weakness, and hyperbilirubinemia.
Capecitabine
Oxaliplatin
Gemcitabine
Ifosfamide
Paclitaxel
Raltitrexed
Zorubicin
Carboplatin